locally manufactured adoptive cellular therapy (ACT) product
2025-089
Phase 1 mab active
Quick answer
locally manufactured adoptive cellular therapy (ACT) product for Malignant Pleural Effusion is a Phase 1 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Indication
- Malignant Pleural Effusion
- Phase
- Phase 1
- Modality
- mab
- Status
- active